Sanjiv Sam Gambhir: Clinical Trials

4 trials sponsored by Sanjiv Sam Gambhir, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 terminated, 1 withdrawn. 3 Phase 1, 1 Not applicable, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 13Completed 2, Terminated 1
Not applicable1Withdrawn 1
Phase 21Completed 1

Follow Sanjiv Sam Gambhir: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Copper Cu 64-DOTA-B-Fab PET/CT in Imaging Patients With Ovarian and Breast Cancer
Computed Tomography, Copper Cu 64-DOTA B-Fab, Laboratory Biomarker Analysis - Ovarian Carcinoma, Breast Carcinoma
Phase 1TerminatedSanjiv Sam Gambhir22016-08-012018-04-05
18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy
18F-fludeoxyglucose (18F-FDG), 18F-FPPRGD2 - Adult Giant Cell Glioblastoma, Adult Glioblastoma
Phase 1 / Phase 2CompletedSanjiv Sam Gambhir252013-03-042019-10-03
Assessing Response to Treatment in Non-Hodgkin's Lymphoma Patients Using 64Cu-DOTA-Rituximab PET/CT
Cu-64 Rituximab - Non-Hodgkin's Lymphoma
Not applicableWithdrawnSanjiv Sam Gambhir2012-01-012016-10-04
Assessing the Suitability of an Imaging Probe for Use in Clinical Cell and Gene Therapy Trials in Cancer and Rheumatoid Arthritis
[18F]FHBG - Brain Cancer, Arthritis, Rheumatoid
Phase 1CompletedSanjiv Sam Gambhir102005-04-012017-03-14

Conditions studied

Brain Neoplasms (2)  ·  Breast Neoplasms (2)  ·  Arthritis, Rheumatoid (1)  ·  Breast Neoplasms, Male (1)  ·  Carcinoma, Non-Small-Cell Lung (1)  ·  Carcinoma, Renal Cell (1)  ·  Central Nervous System Neoplasms (1)  ·  Colonic Neoplasms (1)  ·  Esthesioneuroblastoma, Olfactory (1)  ·  Glioblastoma (1)  ·  Glioma (1)  ·  Gliosarcoma (1)  ·  Hypopharyngeal Neoplasms (1)  ·  Laryngeal Neoplasms (1)  ·  Lymphoma, Non-Hodgkin (1)

Interventions

9-(4-fluoro-3-hydroxymethylbutyl)guanine (1)  ·  FPP(RGD)2 (1)  ·  Fluorodeoxyglucose F18 (1)  ·  Positron-Emission Tomography (1)  ·  Tomography (1)  ·  Tomography, X-Ray Computed (1)

Countries

United States (4)

Top investigators

Sanjiv Gambhir, MD, PhD (2)  ·  Sanjiv Gambhir (1)  ·  Sanjiv Sam Gambhir M.D., Ph.D. (1)

Results publications

PMID 25965900, PMID 26062933, PMID 26611425, PMID 30850872